1. Endemic Fungal Infections in Patients Receiving Tumour Necrosis Factor-α Inhibitor Therapy

   • Jeannina A. Smith
   • Carol A. Kauffman

   Therapy in Practice 17 September 2012 Pages: 1403 - 1415

   

2. The Role of Insulin-Sensitizing Agents in the Treatment of Polycystic Ovary Syndrome

   • Niki Katsiki
   • Eleni Georgiadou
   • Apostolos I. Hatzitolios

   Review Article 17 September 2012 Pages: 1417 - 1431

   

3. Streptokinase and Enoxaparin as an Alternative to Fibrin-Specific Lytic-Based Regimens

   • Roberto R. Giraldez
   • Stephen D. Wiviott
   • Robert P. Giugliano

   Original Research Article 17 September 2012 Pages: 1433 - 1443

   

4. Statin Use and Risk of Colorectal Cancer in a Cohort of Middle-Aged Men in the US

   • E. Dawn Flick
   • Laurel A. Habel
   • Bette J. Caan

   Original Research Article 17 September 2012 Pages: 1445 - 1457

   

5. Budesonide/Formoterol Pressurized Metered-Dose Inhaler

   • Katherine A. Lyseng-Williamson

   Adis Drug Profile 17 September 2012 Pages: 1459 - 1470

   

6. Ixabepilone

   • Marit D. Moen

   Adis Drug Profile 17 September 2012 Pages: 1471 - 1481

   

7. Rabbit Antithymocyte Globulin (Thymoglobulin®)

   • Emma D. Deeks
   • Gillian M. Keating

   Adis Drug Evaluation 17 September 2012 Pages: 1483 - 1512

   

8. Etoricoxib

   • Katherine F. Croom
   • M. Asif A. Siddiqui

   Adis Drug Evaluation 17 September 2012 Pages: 1513 - 1532